| 000 | 00672nam a22002172 4500 | ||
|---|---|---|---|
| 001 | hsl001005924 | ||
| 003 | DGPO | ||
| 005 | 20170826152544.0 | ||
| 008 | 170110m19749999dcu f000 0 eng d | ||
| 040 |
_aGPO _cGPO _dMvI |
||
| 086 | 0 | _aHE 20.3161/A:AN 87/26/ | |
| 099 | _aHE 20.3161/A:AN 87/26/ | ||
| 245 | 0 | 0 | _aHuman leukemia antigen. |
| 260 |
_a[Washington, D.C., _c1974] |
||
| 300 | _av. | ||
| 500 | _aReprinted from JNCI, v.53, no.6, Dec. 1974. | ||
| 500 | _aCRDP Program Historic Shelflist record. | ||
| 505 | 1 | _a1, production and characterization of antisera - 2, purification. | |
| 650 | 0 |
_aLeukemia _xResearch. |
|
| 710 | 2 | _aNational Cancer Institute (U.S.) | |
| 949 |
_aBEV _bFed Docs |
||
| 999 |
_c264153 _d264153 |
||